CLPT

ClearPoint Neuro (CLPT)

About ClearPoint Neuro (CLPT)

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Details

Daily high

$14.35

Daily low

$12.95

Price at open

52 Week High

$30.10

52 Week Low

$9.76

Market cap

368.3M

Dividend yield

0.00%

Volume

787

Avg. volume

607,376

P/E ratio

-14.98

ClearPoint Neuro News